Literature DB >> 3537445

Effect of experimental diabetes on insulin binding by renal basolateral membranes.

R Rabkin, P Hirayama, R A Roth, B H Frank.   

Abstract

Removal of insulin from the peritubular vessels involves binding of insulin to specific receptors in the basolateral membranes (BLM); this is followed by phosphorylation of the receptor which may mediate the actions of the hormone. In most tissues receptor number is regulated by plasma insulin levels and is increased in insulinopenic diabetics. To determine whether cortical BLM insulin receptors are similarly regulated, we studied insulin binding to receptors in BLM from normal control rats and rats with streptozotocin diabetes of varying severity. Specific binding of insulin did not differ between control and modestly insulinopenic diabetics but was increased significantly in the severely insulinopenic diabetics. Insulin treatment returned binding to normal. Scatchard analysis suggested an increase in the binding capacity of the severe diabetic BLM rather than an increase in affinity for insulin. This latter was confirmed by competitive experiments in which similar displacement curves were obtained with control and diabetic membranes. Insulin removed by glomerular filtration binds to specific receptors in the luminal membranes but unlike BLM receptors, phosphorylation of these luminal receptors has not been observed. To determine whether luminal and BLM receptors differ structurally, binding sites in both membranes were affinity labelled with 125I-insulin and the cross linking agent, disuccinimidyl suberate, and subjected to SDS-polyacrylamide gel electrophoresis in the presence of a reducing agent. Autoradiograms revealed that the major specifically labelled subunit in both membranes is a 135,000 Mr species which is more abundant in the BLM. We conclude that insulin receptors in cortical BLM respond to severe insulinopenic diabetes as do receptors in most other tissues.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3537445     DOI: 10.1038/ki.1986.191

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  3 in total

1.  Abnormal regulation of renal kallikrein in experimental diabetes. Effects of insulin on prokallikrein synthesis and activation.

Authors:  A A Jaffa; D H Miller; G S Bailey; J Chao; H S Margolius; R K Mayfield
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

2.  Effect of receptor up-regulation on insulin pharmacokinetics in streptozotocin-treated diabetic rats.

Authors:  H Sato; T Terasaki; K Okumura; A Tsuji
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

3.  Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats.

Authors:  Consuelo Calle; Begoña Maestro; Moisés García-Arencibia
Journal:  BMC Mol Biol       Date:  2008-07-18       Impact factor: 2.946

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.